Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hereditary Prostate Cancer”

88 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 88 results

Not applicableLooking for participantsNCT04052048
What this trial is testing

Active Surveillance SNEP Assay Registry Trial for Prostate Cancer

Who this might be right for
Prostate Cancer Aggressiveness
Immunis.AI 2,000
Not applicableActive Not RecruitingNCT05768776
What this trial is testing

Outpatient Holmium LASER Enucleation of the Prostate: Benefit of MOSES(TM) 2.0 Technology

Who this might be right for
Benign Prostatic HypertrophyHolmium Laser Enucleation of the Prostate
University Hospital, Bordeaux 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT03263650
What this trial is testing

Study of Olaparib Maintenance Following Cabazitaxel-Carbo in Men With AVPC

Who this might be right for
Prostate Cancer AggressivenessProstate Carcinoma
M.D. Anderson Cancer Center 96
Not applicableStudy completedNCT00318240
What this trial is testing

Prostate Cancer Treatment Following Radiation Failure With High Intensity Focused Ultrasound (HIFU)

Who this might be right for
Prostate Cancer
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 40
Testing effectiveness (Phase 2)UnknownNCT05199584
What this trial is testing

A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations

Who this might be right for
Solid Tumors With PTCH1 Loss-of-function Mutations
Endeavor Biomedicines, Inc. 44
Testing effectiveness (Phase 2)Study completedNCT00020046
What this trial is testing

Docetaxel With or Without Thalidomide in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Stage IV Prostate CancerAdenocarcinoma of the ProstateRecurrent Prostate Cancer
National Institutes of Health Clinical Center (CC)
Large-scale testing (Phase 3)Not Yet RecruitingNCT06822751
What this trial is testing

FOsfomycin for Male Urinary Tract Infection

Who this might be right for
Urinary Tract InfectionProstatitisCystitis
University Hospital, Rouen 138
Testing effectiveness (Phase 2)Study completedNCT03437941
What this trial is testing

Study to Evaluate CORT125281 in Combination With Enzalutamide in Patients With mCRPC

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
Corcept Therapeutics 39
Not applicableLooking for participantsNCT03805919
What this trial is testing

Men at High Genetic Risk for Prostate Cancer

Who this might be right for
Prostatic Neoplasms
National Cancer Institute (NCI) 500
Not applicableUnknownNCT00959023
What this trial is testing

Study of Blood and Tumor Samples From Men With an Inherited Risk of Prostate Cancer

Who this might be right for
Prostate Cancer
Institute of Cancer Research, United Kingdom 21,000
Early research (Phase 1)Study completedNCT01351688
What this trial is testing

An Open Label Prostate Cancer Study in Japanese Patients

Who this might be right for
Prostate Cancer
AstraZeneca 13
Not applicableLooking for participantsNCT02705846
What this trial is testing

Analysing Outcomes After Prostate Cancer Diagnosis and Treatment in Carriers of Rare Germline Mutations

Who this might be right for
Prostate Cancer
Institute of Cancer Research, United Kingdom 4,260
Not applicableStudy completedNCT00001469
What this trial is testing

Genetic Analysis of Hereditary Prostate Cancer

Who this might be right for
Prostate Cancer
National Human Genome Research Institute (NHGRI) 7,776
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Not applicableNot Yet RecruitingNCT05681416
What this trial is testing

Prostate Cancer Prevention Clinic for Men With Risk of Familial Prostate Cancer

Who this might be right for
Prostate CancerFamilial Prostate Cancer
Heinrich-Heine University, Duesseldorf 300
Testing effectiveness (Phase 2)Ended earlyNCT00019695
What this trial is testing

Ketoconazole With or Without Alendronate Sodium in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Stage IV Prostate CancerBone MetastasesAdenocarcinoma of the Prostate+1 more
National Cancer Institute (NCI)
Post-approval studies (Phase 4)Study completedNCT04776889
What this trial is testing

The Prognosis of Lipid Reprogramming With Rosuvastatin, in Castrated Egyptian Prostate Cancer Patients

Who this might be right for
Prostate Cancer Metastatic
National Cancer Institute, Egypt 70
Early research (Phase 1)Ended earlyNCT05673109
What this trial is testing

AC176 for the Treatment of Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Accutar Biotechnology Inc 8
Not applicableUnknownNCT02053805
What this trial is testing

Prostate Cancer Screening Among Men With High Risk Genetic Predisposition

Who this might be right for
BRCA1 SyndromeBRCA2 SyndromeLynch Syndrome
Rabin Medical Center 200
Not applicableNot Yet RecruitingNCT06662708
What this trial is testing

Artificial Intelligence Models for Precision Prediction and Treatment of Prostate Cancer

Who this might be right for
Prostate CancerProstate Intraductal CarcinomaProstate Cancer Aggressiveness+2 more
Shao Pengfei 200
Load More Results